caption
stringlengths 6
2.51k
| molecule
stringlengths 1
747
| properties
sequencelengths 1
86
|
|---|---|---|
The molecule is a stabilizing mitochondrial structure and a cholesterol translocation that impacts non-alcoholic fatty liver disease, barth syndrome, and diabetic heart disease. The molecule is a proton trap for oxidative phosphorylation, apoptosis, stabilizing cytochrome oxidase that impacts aging and tangier disease. | CCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCC(C)C | [
"Non-alcoholic fatty liver disease",
"Stabilizing mitochondrial structure",
"Cholesterol translocation",
"Barth syndrome",
"Diabetic heart disease",
"Aging",
"Tangier disease",
"Proton trap for oxidative phosphorylation",
"Apoptosis",
"Stabilizing cytochrome oxidase"
] |
The molecule is a proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase, cholesterol translocation that impacts tangier disease and barth syndrome. The molecule is a apoptosis and a stabilizing mitochondrial structure that impacts aging, non-alcoholic fatty liver disease, and diabetic heart disease. | CCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC(C)CC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCC(C)CC | [
"Proton trap for oxidative phosphorylation",
"Stabilizing cytochrome oxidase",
"Tangier disease",
"Cholesterol translocation",
"Barth syndrome",
"Aging",
"Apoptosis",
"Non-alcoholic fatty liver disease",
"Diabetic heart disease",
"Stabilizing mitochondrial structure"
] |
The molecule is a nutrient, energy source, membrane stabilizer, inflammatory, thyroxine treatment that impacts cancer. The molecule is a energy storage that impacts both pancreatitis and obesity. The molecule is a fat storage that impacts cardiovascular disease, atherosclerosis, and metabolic syndrome. | CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCC(C)C | [
"Cancer",
"nutrient",
"Energy source",
"Membrane stabilizer",
"inflammatory",
"Thyroxine treatment",
"Pancreatitis",
"Obesity",
"Energy storage",
"Cardiovascular disease",
"Atherosclerosis",
"Metabolic syndrome",
"Fat storage"
] |
The molecule is a emulsifier, a energy storage, and pharmaceutical. The molecule is a signalling molecule, surfactant, membrane stabilizer, energy source. | C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O)[C@@H]2O | [
"Pharmaceutical",
"Emulsifier",
"Energy storage",
"signalling molecule",
"surfactant",
"Membrane stabilizer",
"Energy source"
] |
The molecule is a apoptosis, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation that impacts barth syndrome and diabetic heart disease. The molecule is a stabilizing mitochondrial structure and a cholesterol translocation that impacts non-alcoholic fatty liver disease, aging, and tangier disease. | CCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC(C)CC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCC | [
"Barth syndrome",
"Apoptosis",
"Stabilizing cytochrome oxidase",
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease",
"Stabilizing mitochondrial structure",
"Non-alcoholic fatty liver disease",
"Cholesterol translocation",
"Aging",
"Tangier disease"
] |
The molecule is a cholesterol translocation, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts barth syndrome and tangier disease. The molecule is a proton trap for oxidative phosphorylation and a apoptosis that impacts non-alcoholic fatty liver disease, aging, and diabetic heart disease. | CC/C=C\C/C=C\C/C=C\CCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\CCCCCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCCCCCCCC | [
"Barth syndrome",
"Cholesterol translocation",
"Stabilizing cytochrome oxidase",
"Stabilizing mitochondrial structure",
"Tangier disease",
"Non-alcoholic fatty liver disease",
"Aging",
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease",
"Apoptosis"
] |
The molecule is a surfactant and a signalling molecule, belonging to the anti fertility class of molecules. The molecule is a energy source, emulsifier, energy storage, membrane stabilizer. | CC1=C2C(/C=C(\C)C(=O)O)CCC(C)C2CC1 | [
"surfactant",
"anti fertility",
"signalling molecule",
"Energy source",
"Emulsifier",
"Energy storage",
"Membrane stabilizer"
] |
The molecule is both a cancer treatment and a aurora kinase inhibitor. | Cc1cc(CN2CCN(c3c(Br)cnc4nc(-c5ccc(Cn6cccn6)cc5)[nH]c34)CC2)no1 | [
"cancer treatment",
"aurora kinase inhibitor"
] |
The molecule is a membrane stabilizer and a inflammatory that impacts metabolic syndrome, thyroxine treatment, atherosclerosis, and cardiovascular disease. The molecule is a nutrient and energy storage, and it impacts obesity. The molecule is a energy source and a fat storage, impacting both pancreatitis and cancer. | CCCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCCCC(C)C | [
"Metabolic syndrome",
"Membrane stabilizer",
"Thyroxine treatment",
"Atherosclerosis",
"Cardiovascular disease",
"inflammatory",
"nutrient",
"Energy storage",
"Obesity",
"Energy source",
"Fat storage",
"Pancreatitis",
"Cancer"
] |
The molecule is a energy source, nutritional supplement, apoptosis, surfactant. The molecule is a cholesterol translocation, food additive, membrane stabilizer, energy storage, and smooth. The molecule is a stabilizing mitochondrial structure that impacts diabetic heart disease, tangier disease, and non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, emulsifier that impacts aging and barth syndrome. | CC(C)CCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCC(C)C)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCC(C)C | [
"Energy source",
"Nutritional supplement",
"Apoptosis",
"surfactant",
"Cholesterol translocation",
"food additive",
"Smooth",
"Membrane stabilizer",
"Energy storage",
"Diabetic heart disease",
"Tangier disease",
"Stabilizing mitochondrial structure",
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase",
"Aging",
"Barth syndrome",
"Proton trap for oxidative phosphorylation",
"Emulsifier"
] |
The molecule is a nutritional supplement and a stabilizing cytochrome oxidase, impacting both non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a energy storage, food additive, surfactant, cholesterol translocation, energy source. The molecule is a apoptosis, a membrane stabilizer, and a proton trap for oxidative phosphorylation, and it impacts barth syndrome. The molecule is a emulsifier and a stabilizing mitochondrial structure, which impacts both aging and tangier disease, and is characterized as smooth. | CCC(C)CCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCC(C)C | [
"Non-alcoholic fatty liver disease",
"Diabetic heart disease",
"Nutritional supplement",
"Stabilizing cytochrome oxidase",
"Energy storage",
"food additive",
"surfactant",
"Cholesterol translocation",
"Energy source",
"Apoptosis",
"Membrane stabilizer",
"Barth syndrome",
"Proton trap for oxidative phosphorylation",
"Aging",
"Smooth",
"Emulsifier",
"Tangier disease",
"Stabilizing mitochondrial structure"
] |
The molecule is a cholesterol translocation and a apoptosis that impacts non-alcoholic fatty liver disease, barth syndrome, and diabetic heart disease. The molecule is a stabilizing mitochondrial structure, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation that impacts tangier disease and aging. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC | [
"Non-alcoholic fatty liver disease",
"Barth syndrome",
"Cholesterol translocation",
"Diabetic heart disease",
"Apoptosis",
"Stabilizing mitochondrial structure",
"Stabilizing cytochrome oxidase",
"Tangier disease",
"Proton trap for oxidative phosphorylation",
"Aging"
] |
The molecule is a stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, cholesterol translocation that impacts tangier disease and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase and a apoptosis that impacts barth syndrome, non-alcoholic fatty liver disease, and aging. | CCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCC(C)CC | [
"Stabilizing mitochondrial structure",
"Tangier disease",
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease",
"Cholesterol translocation",
"Barth syndrome",
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase",
"Apoptosis",
"Aging"
] |
The molecule is a cholesterol translocation, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase that impacts diabetic heart disease and tangier disease. The molecule is a stabilizing mitochondrial structure and a apoptosis that impacts non-alcoholic fatty liver disease, barth syndrome, and aging. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCC/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC | [
"Diabetic heart disease",
"Cholesterol translocation",
"Proton trap for oxidative phosphorylation",
"Tangier disease",
"Stabilizing cytochrome oxidase",
"Non-alcoholic fatty liver disease",
"Barth syndrome",
"Aging",
"Stabilizing mitochondrial structure",
"Apoptosis"
] |
At ph 1.2 or ph 9, decomposition is rapid. The molecule has Faint almond odor (technical); mild aromatic odor (end-use). | CCCCOC(=O)C(C)Oc1ccc(Oc2ccc(C#N)cc2F)cc1 | [
"Decomposition_evaluation",
"Odor_evaluation"
] |
The molecule is a nutrient, energy storage, fat storage that impacts cardiovascular disease, pancreatitis, and metabolic syndrome. The molecule is a inflammatory and membrane stabilizer with an effect on cancer. The molecule is a energy source and thyroxine treatment, impacting both atherosclerosis and obesity. | CCCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC | [
"nutrient",
"Cardiovascular disease",
"Pancreatitis",
"Energy storage",
"Fat storage",
"Metabolic syndrome",
"inflammatory",
"Membrane stabilizer",
"Cancer",
"Atherosclerosis",
"Energy source",
"Obesity",
"Thyroxine treatment"
] |
The molecule is a energy source, inflammatory, nutrient that impacts atherosclerosis, metabolic syndrome, and pancreatitis. The molecule is a fat storage that affects cancer by impacting obesity. The molecule is a membrane stabilizer and energy storage, belonging to the thyroxine treatment class of molecules, and impacts cardiovascular disease. | CCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCC | [
"Atherosclerosis",
"Energy source",
"inflammatory",
"nutrient",
"Metabolic syndrome",
"Pancreatitis",
"Cancer",
"Obesity",
"Fat storage",
"Membrane stabilizer",
"Energy storage",
"Cardiovascular disease",
"Thyroxine treatment"
] |
The molecule is a fat storage and thyroxine treatment, and it impacts pancreatitis. The molecule is a nutrient that impacts atherosclerosis, cardiovascular disease, and metabolic syndrome. | CC/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)OC[C@H](COC(=O)CCCC/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC | [
"Pancreatitis",
"Thyroxine treatment",
"Fat storage",
"nutrient",
"Atherosclerosis",
"Cardiovascular disease",
"Metabolic syndrome"
] |
It belongs to the light-emitting class of molecules. | CC1(C)c2ccccc2-c2ccc(-n3c4ccccc4c4cc(-c5ccc(N(c6ccc(-c7ccccc7)cc6)c6cc7ccccc7c7c6oc6ccccc67)cc5)ccc43)cc21 | [
"light-emitting"
] |
The molecule is a proton trap for oxidative phosphorylation, apoptosis, stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease and aging. The molecule is a cholesterol translocation and a stabilizing cytochrome oxidase that impacts diabetic heart disease, tangier disease, and barth syndrome. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCC/C=C\C/C=C\C/C=C\C/C=C\CC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCCCCCC | [
"Proton trap for oxidative phosphorylation",
"Apoptosis",
"Non-alcoholic fatty liver disease",
"Stabilizing mitochondrial structure",
"Aging",
"Diabetic heart disease",
"Tangier disease",
"Cholesterol translocation",
"Stabilizing cytochrome oxidase",
"Barth syndrome"
] |
The molecule is a stabilizing mitochondrial structure, stabilizing cytochrome oxidase, apoptosis that impacts tangier disease and aging. The molecule is a proton trap for oxidative phosphorylation and a cholesterol translocation that impacts barth syndrome, non-alcoholic fatty liver disease, and diabetic heart disease. | CCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCC(C)C | [
"Tangier disease",
"Stabilizing mitochondrial structure",
"Aging",
"Stabilizing cytochrome oxidase",
"Apoptosis",
"Proton trap for oxidative phosphorylation",
"Cholesterol translocation",
"Barth syndrome",
"Non-alcoholic fatty liver disease",
"Diabetic heart disease"
] |
It belongs to the anti hypertensive class of molecules. | COc1ccc(C(=O)NC2c3cc(C#N)ccc3C(=O)C(C)(C)C2O)cc1 | [
"anti hypertensive"
] |
The molecule is a surfactant that is fruity and tropical. The molecule is a nutrient, a energy storage, a emulsifier, and fatty. The molecule is plum skin, green, and pear skin. The molecule is a membrane stabilizer, a energy source, a flavoring agent, and waxy. | O=C1CC(c2ccc(O)cc2)Oc2cc(OC3OC(CO)C(O)C(O)C3O)ccc21 | [
"fruity",
"tropical",
"surfactant",
"nutrient",
"fatty",
"Energy storage",
"Emulsifier",
"plum skin",
"green",
"pear skin",
"Membrane stabilizer",
"Energy source",
"Flavoring agent",
"waxy"
] |
The molecule is a stabilizing cytochrome oxidase, a stabilizing mitochondrial structure, a surfactant, and smooth. The molecule is a emulsifier, nutritional supplement, energy storage, food additive that impacts barth syndrome. The molecule is a energy source, a proton trap for oxidative phosphorylation, and a cholesterol translocation, and it impacts diabetic heart disease. The molecule is a membrane stabilizer and a apoptosis that impacts tangier disease, aging, and non-alcoholic fatty liver disease. | CCCCCC/C=C\C=C/CCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCC/C=C\C=C/CCCCCC | [
"Stabilizing cytochrome oxidase",
"Smooth",
"Stabilizing mitochondrial structure",
"surfactant",
"Barth syndrome",
"Emulsifier",
"Nutritional supplement",
"Energy storage",
"food additive",
"Diabetic heart disease",
"Energy source",
"Proton trap for oxidative phosphorylation",
"Cholesterol translocation",
"Tangier disease",
"Aging",
"Membrane stabilizer",
"Apoptosis",
"Non-alcoholic fatty liver disease"
] |
The molecule is a proton trap for oxidative phosphorylation and a stabilizing cytochrome oxidase that impacts barth syndrome, tangier disease, and aging. The molecule is a cholesterol translocation, apoptosis, stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease and diabetic heart disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC | [
"Barth syndrome",
"Proton trap for oxidative phosphorylation",
"Tangier disease",
"Stabilizing cytochrome oxidase",
"Aging",
"Cholesterol translocation",
"Non-alcoholic fatty liver disease",
"Apoptosis",
"Diabetic heart disease",
"Stabilizing mitochondrial structure"
] |
The molecule is a cholesterol translocation and a stabilizing mitochondrial structure that impacts diabetic heart disease, tangier disease, and aging. The molecule is a stabilizing cytochrome oxidase, apoptosis, proton trap for oxidative phosphorylation that impacts barth syndrome and non-alcoholic fatty liver disease. | CCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCC(C)CC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCCC(C)C | [
"Cholesterol translocation",
"Diabetic heart disease",
"Stabilizing mitochondrial structure",
"Tangier disease",
"Aging",
"Barth syndrome",
"Stabilizing cytochrome oxidase",
"Non-alcoholic fatty liver disease",
"Apoptosis",
"Proton trap for oxidative phosphorylation"
] |
The molecule is a apoptosis, stabilizing mitochondrial structure, cholesterol translocation that impacts barth syndrome and non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase and a proton trap for oxidative phosphorylation that impacts aging, tangier disease, and diabetic heart disease. | CCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCC(C)C | [
"Apoptosis",
"Barth syndrome",
"Stabilizing mitochondrial structure",
"Cholesterol translocation",
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase",
"Proton trap for oxidative phosphorylation",
"Aging",
"Tangier disease",
"Diabetic heart disease"
] |
The molecule is a anti viral, viral replication inhibitor, hcv ns5b inhibitor that impacts hcv treatment and hepatitis c treatment. | OCC1OC2=CC=C(Cl)N(F)C2=C2Cc3ccccc3N21 | [
"anti viral",
"hcv treatment",
"hepatitis c treatment",
"viral replication inhibitor",
"hcv ns5b inhibitor"
] |
The molecule is a proton trap for oxidative phosphorylation, apoptosis, cholesterol translocation that impacts aging and non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase and a stabilizing mitochondrial structure that impacts diabetic heart disease, barth syndrome, and tangier disease. | CCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC(C)CC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCC | [
"Proton trap for oxidative phosphorylation",
"Aging",
"Apoptosis",
"Non-alcoholic fatty liver disease",
"Cholesterol translocation",
"Stabilizing cytochrome oxidase",
"Diabetic heart disease",
"Barth syndrome",
"Tangier disease",
"Stabilizing mitochondrial structure"
] |
The molecule is a phosphorescent emitter and is both phosphorescent and belongs to the electroluminescent and organic electroluminescent device classes of molecules. | CC1(C)c2ccccc2-c2cc3c(cc21)NC1C=CC=CC31 | [
"phosphorescent emitter",
"electroluminescent",
"phosphorescent",
"organic electroluminescent device"
] |
The molecule is both a ns5a inhibitor and a hcv inhibitor. | COC(=O)CNC(=O)C1(NC(=O)C2C3CCC(C3)C2c2ncc(-c3ccc(-c4ccc(-c5cnc(C6CCCN6C(=O)C(NC(=O)OC)C(C)C)[nH]5)cc4)cc3)[nH]2)CCCCC1 | [
"ns5a inhibitor",
"hcv inhibitor"
] |
The molecule is electroluminescent. | C=CC=C(C=CC)c1ccc(N(c2ccc(-c3ccccc3)cc2)c2ccc(C3(c4ccccc4)c4ccccc4-c4ccccc43)cc2)cc1 | [
"electroluminescent"
] |
The molecule is a proton trap for oxidative phosphorylation, apoptosis, stabilizing cytochrome oxidase that impacts diabetic heart disease and non-alcoholic fatty liver disease. The molecule is a stabilizing mitochondrial structure and a cholesterol translocation that impacts barth syndrome, tangier disease, and aging. | CCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C | [
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease",
"Apoptosis",
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase",
"Barth syndrome",
"Tangier disease",
"Aging",
"Stabilizing mitochondrial structure",
"Cholesterol translocation"
] |
The molecule is a nutrient, a flavoring agent, vanilla, sweet, floral, and nutty. | CC(C)CCOC(=O)/C=C\c1ccccc1 | [
"vanilla",
"nutrient",
"sweet",
"floral",
"Flavoring agent",
"nutty"
] |
The molecule is a organic electroluminescent device and belongs to the high luminous efficiency class of molecules, known to have an effect on organic electroluminescence and is characterized as electroluminescent. | c1ccc(-c2ccc(-c3cc4oc5ccc(-n6c7ccccc7c7ccccc76)cc5c4c4c3oc3ccc(-n5c6ccccc6c6ccccc65)cc34)cc2)cc1 | [
"organic electroluminescence",
"electroluminescent",
"organic electroluminescent device",
"high luminous efficiency"
] |
Toxic gases and vapors (such as oxides of nitrogen) may be released when some sol silver cmpd decomp. silver metal and soluble silver compounds/ | [Ag] | [
"Decomposition_evaluation"
] |
The molecule is a energy storage and a nutrient, which impacts cardiovascular disease, metabolic syndrome, and cancer, and is characterized as thyroxine treatment. The molecule is a inflammatory that impacts both pancreatitis and atherosclerosis. The molecule is a energy source, a membrane stabilizer, and a fat storage, and it impacts obesity. | CCC(C)CCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCC(C)C | [
"Energy storage",
"nutrient",
"Cardiovascular disease",
"Metabolic syndrome",
"Thyroxine treatment",
"Cancer",
"Pancreatitis",
"Atherosclerosis",
"inflammatory",
"Energy source",
"Obesity",
"Membrane stabilizer",
"Fat storage"
] |
The molecule is a cholesterol translocation, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure that impacts diabetic heart disease and non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase and a apoptosis that impacts aging, barth syndrome, and tangier disease. | CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCC(C)C)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C | [
"Cholesterol translocation",
"Proton trap for oxidative phosphorylation",
"Stabilizing mitochondrial structure",
"Diabetic heart disease",
"Non-alcoholic fatty liver disease",
"Aging",
"Stabilizing cytochrome oxidase",
"Barth syndrome",
"Apoptosis",
"Tangier disease"
] |
The molecule is a stabilizing mitochondrial structure, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, cholesterol translocation that impacts barth syndrome. The molecule is a apoptosis that impacts non-alcoholic fatty liver disease, tangier disease, diabetic heart disease, and aging. | CCCCC/C=C\C/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCCCCCCCCCCCCCC | [
"Stabilizing mitochondrial structure",
"Stabilizing cytochrome oxidase",
"Proton trap for oxidative phosphorylation",
"Cholesterol translocation",
"Barth syndrome",
"Non-alcoholic fatty liver disease",
"Tangier disease",
"Diabetic heart disease",
"Apoptosis",
"Aging"
] |
The molecule has Mustard-like odor. | CC(=O)OC1CC(C)OC(C)O1 | [
"Odor_evaluation"
] |
The molecule is thyroxine treatment and it impacts both metabolic syndrome and atherosclerosis. The molecule is a fat storage and a nutrient, impacting both cardiovascular disease and pancreatitis. | CCCCC/C=C\C/C=C\CCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC | [
"Metabolic syndrome",
"Atherosclerosis",
"Thyroxine treatment",
"Cardiovascular disease",
"Fat storage",
"nutrient",
"Pancreatitis"
] |
The molecule is a kinase inhibitor. | CCCc1c(-c2ccc(O)cn2)nc2ccc3[nH]ncc3c2c1C | [
"kinase inhibitor"
] |
The molecule is a cholesterol translocation and a stabilizing mitochondrial structure that impacts aging, barth syndrome, and diabetic heart disease. The molecule is a apoptosis, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation that impacts tangier disease and non-alcoholic fatty liver disease. | CCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC | [
"Aging",
"Cholesterol translocation",
"Barth syndrome",
"Stabilizing mitochondrial structure",
"Diabetic heart disease",
"Apoptosis",
"Stabilizing cytochrome oxidase",
"Tangier disease",
"Proton trap for oxidative phosphorylation",
"Non-alcoholic fatty liver disease"
] |
The molecule is a stabilizing mitochondrial structure and a proton trap for oxidative phosphorylation that impacts barth syndrome, non-alcoholic fatty liver disease, and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase, apoptosis, cholesterol translocation that impacts aging and tangier disease. | CCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCC | [
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Non-alcoholic fatty liver disease",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Aging",
"Stabilizing cytochrome oxidase",
"Apoptosis",
"Cholesterol translocation",
"Tangier disease"
] |
The molecule is a crth2 antagonist and belongs to the inflammatory treatment class of molecules. | NC(=S)N(c1ccccc1)c1ccc(F)cc1 | [
"crth2 antagonist",
"inflammatory treatment"
] |
The molecule is a prmt5 inhibitor. | Cc1cc(C2CCC(C)CN2C(=O)C(=O)Nc2cnc(N)c(C)c2)ccn1 | [
"prmt5 inhibitor"
] |
The molecule is a stabilizing cytochrome oxidase and a cholesterol translocation that impacts aging, non-alcoholic fatty liver disease, and barth syndrome. The molecule is a apoptosis, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation that impacts tangier disease and diabetic heart disease. | CC/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCC/C=C\C/C=C\C/C=C\CC | [
"Aging",
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase",
"Barth syndrome",
"Cholesterol translocation",
"Apoptosis",
"Stabilizing mitochondrial structure",
"Tangier disease",
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease"
] |
It has an effect on colorectal cancer, and impacts parkinson's disease, cardiovascular disease, and alzheimer's disease. It has an effect on breast cancer, and impacts stomach cancer, diabetes mellitus, and seizure. | CCCCCCCC/C=C\C/C=C\C/C=C\CCCC(=O)OC[C@H](COC[C@@H](O)COP(=O)(O)O[C@H]1C(O)C(O)C(O)[C@@H](OP(=O)(O)O)C1O)OC(=O)CCCCCCCCCCCCCCCCC | [
"Parkinson's disease",
"Colorectal cancer",
"Cardiovascular disease",
"Alzheimer's Disease",
"Breast cancer",
"Stomach cancer",
"Diabetes mellitus",
"Seizure"
] |
The molecule is metallic and balsam, and it impacts muscle cramp . The molecule is a plant metabolite and a food and nutrition, it impacts muscle weakness, and is geranium. The molecule is apricot and it impacts both headache and anxiety. It impacts vomiting, fatigue, nausea, and paralysis. It impacts hypotension, collapse, and depression. The molecule is a photosensitizing agent that impacts tremor and is both anti inflammatory and peach. The molecule is rose and powdery, and it impacts coma. The molecule is a environmental contaminant and pharmaceutical, impacting both hypertension and hypoglycemia. | CC(C)CC(=O)OCc1ccccc1 | [
"metallic",
"Muscle cramp ",
"balsam",
"plant metabolite",
"Food and nutrition",
"geranium",
"Muscle weakness",
"Headache",
"apricot",
"Anxiety",
"Vomiting",
"Fatigue",
"Nausea",
"Paralysis",
"Hypotension",
"Collapse",
"Depression",
"Tremor",
"photosensitizing agent",
"anti inflammatory",
"peach",
"rose",
"Coma",
"powdery",
"Hypertension",
"Hypoglycemia",
"Pharmaceutical",
"environmental contaminant"
] |
The molecule is a nutrient, a fat storage, and thyroxine treatment. It impacts metabolic syndrome, pancreatitis, cardiovascular disease, and atherosclerosis. | CCCCC/C=C\C/C=C\CCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCC/C=C\C/C=C\CCCCC | [
"nutrient",
"Fat storage",
"Thyroxine treatment",
"Metabolic syndrome",
"Pancreatitis",
"Cardiovascular disease",
"Atherosclerosis"
] |
The molecule is a stabilizing cytochrome oxidase, cholesterol translocation, apoptosis that impacts diabetic heart disease and barth syndrome. The molecule is a stabilizing mitochondrial structure and a proton trap for oxidative phosphorylation that impacts tangier disease, aging, and non-alcoholic fatty liver disease. | CCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@H](COC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC | [
"Stabilizing cytochrome oxidase",
"Diabetic heart disease",
"Cholesterol translocation",
"Apoptosis",
"Barth syndrome",
"Tangier disease",
"Stabilizing mitochondrial structure",
"Aging",
"Non-alcoholic fatty liver disease",
"Proton trap for oxidative phosphorylation"
] |
The molecule is a proton trap for oxidative phosphorylation, apoptosis, stabilizing cytochrome oxidase that impacts barth syndrome and aging. The molecule is a cholesterol translocation and a stabilizing mitochondrial structure that impacts tangier disease, non-alcoholic fatty liver disease, and diabetic heart disease. | CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCCC | [
"Barth syndrome",
"Aging",
"Proton trap for oxidative phosphorylation",
"Apoptosis",
"Stabilizing cytochrome oxidase",
"Cholesterol translocation",
"Tangier disease",
"Non-alcoholic fatty liver disease",
"Diabetic heart disease",
"Stabilizing mitochondrial structure"
] |
The molecule is a cholesterol translocation and a proton trap for oxidative phosphorylation that impacts barth syndrome, aging, and diabetic heart disease. The molecule is a apoptosis, stabilizing mitochondrial structure, stabilizing cytochrome oxidase that impacts non-alcoholic fatty liver disease and tangier disease. | CC/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC | [
"Barth syndrome",
"Aging",
"Cholesterol translocation",
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease",
"Apoptosis",
"Non-alcoholic fatty liver disease",
"Stabilizing mitochondrial structure",
"Stabilizing cytochrome oxidase",
"Tangier disease"
] |
The molecule is a stabilizing mitochondrial structure, stabilizing cytochrome oxidase, cholesterol translocation, apoptosis that impacts diabetic heart disease. The molecule is a proton trap for oxidative phosphorylation that impacts tangier disease, non-alcoholic fatty liver disease, barth syndrome, and aging. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC | [
"Stabilizing mitochondrial structure",
"Diabetic heart disease",
"Stabilizing cytochrome oxidase",
"Cholesterol translocation",
"Apoptosis",
"Tangier disease",
"Proton trap for oxidative phosphorylation",
"Non-alcoholic fatty liver disease",
"Barth syndrome",
"Aging"
] |
The molecule is a stabilizing mitochondrial structure and a apoptosis that impacts aging, non-alcoholic fatty liver disease, and barth syndrome. The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, cholesterol translocation that impacts tangier disease and diabetic heart disease. | CCCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC | [
"Stabilizing mitochondrial structure",
"Aging",
"Non-alcoholic fatty liver disease",
"Apoptosis",
"Barth syndrome",
"Tangier disease",
"Stabilizing cytochrome oxidase",
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease",
"Cholesterol translocation"
] |
The molecule is a nutrient that impacts both pancreatitis and cardiovascular disease. The molecule is a fat storage that impacts atherosclerosis, metabolic syndrome, and thyroxine treatment. | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCCCCCC | [
"Pancreatitis",
"nutrient",
"Cardiovascular disease",
"Atherosclerosis",
"Fat storage",
"Metabolic syndrome",
"Thyroxine treatment"
] |
The molecule is a nutrient. | C=CCSSCC(NC(=O)CCC(N)C(=O)O)C(=O)O | [
"nutrient"
] |
The molecule is both a mmp13 inhibitor and a metalloprotease inhibitor. | CCOC=C(N)C(=O)OCC | [
"mmp13 inhibitor",
"metalloprotease inhibitor"
] |
The molecule is a nutrient that impacts both metabolic syndrome and thyroxine treatment. The molecule is a fat storage that impacts atherosclerosis, cardiovascular disease, and pancreatitis. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC | [
"Metabolic syndrome",
"Thyroxine treatment",
"nutrient",
"Atherosclerosis",
"Cardiovascular disease",
"Fat storage",
"Pancreatitis"
] |
The molecule is a apoptosis, proton trap for oxidative phosphorylation, cholesterol translocation that impacts aging and diabetic heart disease. The molecule is a stabilizing mitochondrial structure and a stabilizing cytochrome oxidase that impacts non-alcoholic fatty liver disease, barth syndrome, and tangier disease. | CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCC | [
"Aging",
"Apoptosis",
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease",
"Cholesterol translocation",
"Non-alcoholic fatty liver disease",
"Barth syndrome",
"Stabilizing mitochondrial structure",
"Stabilizing cytochrome oxidase",
"Tangier disease"
] |
The molecule is a diabetes treatment and belongs to the obesity treatment class of molecules. | CC(C)(O)COc1ccc2cc(-n3ccnc(SCCc4ccccc4)c3=O)ccc2n1 | [
"diabetes treatment",
"obesity treatment"
] |
The molecule is a environmental contaminant that impacts both porphyria and porphyria cutanea tarda. The molecule is a hazardous air pollutant, a air pollutant, and a carcinogenic agent, and it impacts arthritis. The molecule is a fungicide, a carcinogen, and a persistent organic pollutant, and it impacts osteoporosis. The molecule is a water pollutant and belongs to the pesticide class of molecules, impacting liver disease and is characterized as agrochemical. | CCC(C)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1OC(C)=O | [
"environmental contaminant",
"Porphyria",
"Porphyria cutanea tarda",
"Hazardous air pollutant",
"Arthritis",
"Air pollutant",
"carcinogenic agent",
"fungicide",
"Osteoporosis",
"Carcinogen",
"persistent organic pollutant",
"Liver disease",
"pesticide",
"Water pollutant",
"agrochemical"
] |
It belongs to the anti microbial class of molecules. | COc1ccc(Cc2cncnc2N)cc1OC | [
"anti microbial"
] |
The molecule is a nutrient that impacts breast cancer, cervical cancer, atherosclerosis, and ulcerative colitis. | CCCCC/C=C\C[C@@H](O)[C@H](O)CCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCC/C=C\C/C=C\C/C=C\CCCCCC | [
"nutrient",
"Breast cancer",
"Cervical cancer",
"Atherosclerosis",
"Ulcerative colitis"
] |
The molecule is a nutrient, flavoring agent, anti infective agent and belongs to the central nervous system depressant class of molecules. The molecule is a personal care products and food and nutrition, belonging to the pharmaceutical class of molecules, and it impacts both diarrhea and vomiting. | CCCCCC(O)CC(=O)OCC | [
"central nervous system depressant",
"nutrient",
"Flavoring agent",
"anti infective agent",
"Diarrhea",
"Vomiting",
"Pharmaceutical",
"Personal care products",
"Food and nutrition"
] |
The molecule is a emulsifier, a stabilizing cytochrome oxidase, and a stabilizing mitochondrial structure, and it impacts diabetic heart disease. The molecule is a nutritional supplement and a membrane stabilizer that impacts barth syndrome, aging, and non-alcoholic fatty liver disease. The molecule is a energy storage, a cholesterol translocation, a energy source, and smooth. The molecule is a food additive, surfactant, apoptosis, proton trap for oxidative phosphorylation that impacts tangier disease. | CC(C)CCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCC(C)C)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCC(C)C | [
"Diabetic heart disease",
"Emulsifier",
"Stabilizing cytochrome oxidase",
"Stabilizing mitochondrial structure",
"Nutritional supplement",
"Barth syndrome",
"Aging",
"Membrane stabilizer",
"Non-alcoholic fatty liver disease",
"Energy storage",
"Cholesterol translocation",
"Smooth",
"Energy source",
"food additive",
"surfactant",
"Apoptosis",
"Tangier disease",
"Proton trap for oxidative phosphorylation"
] |
The molecule is a platelet aggregation inhibitor. | CCCCS(=O)(=O)NCC(=O)CC(=O)OC | [
"platelet aggregation inhibitor"
] |
The molecule is a proton trap for oxidative phosphorylation, stabilizing mitochondrial structure, apoptosis that impacts diabetic heart disease and non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase and a cholesterol translocation that impacts aging, tangier disease, and barth syndrome. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCCCC/C=C\C/C=C\C/C=C\CC)OC(=O)CCCC/C=C\C/C=C\C/C=C\C/C=C\CC | [
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease",
"Non-alcoholic fatty liver disease",
"Stabilizing mitochondrial structure",
"Apoptosis",
"Stabilizing cytochrome oxidase",
"Cholesterol translocation",
"Aging",
"Tangier disease",
"Barth syndrome"
] |
The molecule is a fat storage that impacts both atherosclerosis and cardiovascular disease. The molecule is a nutrient that impacts thyroxine treatment, pancreatitis, and metabolic syndrome. | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC | [
"Fat storage",
"Atherosclerosis",
"Cardiovascular disease",
"Thyroxine treatment",
"Pancreatitis",
"Metabolic syndrome",
"nutrient"
] |
The molecule is a cdk inhibitor. | CCC(N)COC(O)C(N)CC(C)C | [
"cdk inhibitor"
] |
The molecule is a kinase inhibitor, a tumor treatment, and a protein kinase inhibitor. | Nc1nc(Cl)cc(Oc2ccc3c(C(=O)O)cnn3c2)n1 | [
"kinase inhibitor",
"tumor treatment",
"protein kinase inhibitor"
] |
The molecule is a stabilizing cytochrome oxidase, cholesterol translocation, apoptosis that impacts barth syndrome and diabetic heart disease. The molecule is a stabilizing mitochondrial structure and a proton trap for oxidative phosphorylation that impacts aging, tangier disease, and non-alcoholic fatty liver disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCC | [
"Stabilizing cytochrome oxidase",
"Barth syndrome",
"Cholesterol translocation",
"Apoptosis",
"Diabetic heart disease",
"Aging",
"Tangier disease",
"Stabilizing mitochondrial structure",
"Non-alcoholic fatty liver disease",
"Proton trap for oxidative phosphorylation"
] |
The molecule is a proton trap for oxidative phosphorylation and a cholesterol translocation that impacts tangier disease, non-alcoholic fatty liver disease, and aging. The molecule is a apoptosis, stabilizing mitochondrial structure, stabilizing cytochrome oxidase that impacts diabetic heart disease and barth syndrome. | CCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCC(C)C | [
"Tangier disease",
"Proton trap for oxidative phosphorylation",
"Non-alcoholic fatty liver disease",
"Aging",
"Cholesterol translocation",
"Diabetic heart disease",
"Apoptosis",
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Stabilizing cytochrome oxidase"
] |
The molecule is a stabilizing mitochondrial structure, cholesterol translocation, proton trap for oxidative phosphorylation that impacts aging and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase and a apoptosis that impacts barth syndrome, tangier disease, and non-alcoholic fatty liver disease. | CCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC | [
"Stabilizing mitochondrial structure",
"Cholesterol translocation",
"Aging",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Stabilizing cytochrome oxidase",
"Barth syndrome",
"Tangier disease",
"Apoptosis",
"Non-alcoholic fatty liver disease"
] |
The molecule is a pi3k inhibitor that impacts asthma treatment. | COCC1COCCN1S(=O)(=O)c1ccc(C)c(-c2cnc(N)c(-c3cc(C)no3)c2)c1 | [
"asthma treatment",
"pi3k inhibitor"
] |
The molecule is a fxa inhibitor and belongs to the anti coagulant class of molecules. | CC1Cc2sc(C(=O)N3CCN(S(=O)(=O)c4ccc5cc(Cl)ccc5c4)CC3C(N)=O)nc2CN1 | [
"anti coagulant",
"fxa inhibitor"
] |
The molecule is a proton trap for oxidative phosphorylation and a energy source, impacting both barth syndrome and diabetic heart disease. The molecule is a food additive, membrane stabilizer, cholesterol translocation, apoptosis, and smooth. The molecule is a energy storage, a stabilizing mitochondrial structure, and a stabilizing cytochrome oxidase, and it impacts tangier disease. The molecule is a surfactant, emulsifier, nutritional supplement that impacts aging and non-alcoholic fatty liver disease. | CCC(C)CCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCC(C)C)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCC(C)C | [
"Barth syndrome",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Energy source",
"food additive",
"Membrane stabilizer",
"Smooth",
"Cholesterol translocation",
"Apoptosis",
"Energy storage",
"Stabilizing mitochondrial structure",
"Tangier disease",
"Stabilizing cytochrome oxidase",
"surfactant",
"Aging",
"Emulsifier",
"Non-alcoholic fatty liver disease",
"Nutritional supplement"
] |
The molecule is a stabilizing cytochrome oxidase, apoptosis, cholesterol translocation that impacts aging and diabetic heart disease. The molecule is a stabilizing mitochondrial structure and a proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease, barth syndrome, and tangier disease. | CCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC)OC(=O)CCCCCCCCCCCCC(C)CC | [
"Stabilizing cytochrome oxidase",
"Aging",
"Diabetic heart disease",
"Apoptosis",
"Cholesterol translocation",
"Non-alcoholic fatty liver disease",
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Tangier disease",
"Proton trap for oxidative phosphorylation"
] |
The molecule is a allergen, which is a member of the trichomonicide class of molecules, and it is sandalwood, deep, sweet, and woody. | CC(C)=CCc1occc1C | [
"trichomonicide",
"sandalwood",
"deep",
"sweet",
"woody",
"allergen"
] |
The molecule is a protein tyrosine kinase inhibitor that impacts cancer treatment. | Nc1cccc(-c2cnn3cc(-c4ccncc4)cnc23)c1 | [
"protein tyrosine kinase inhibitor",
"cancer treatment"
] |
The molecule is a jak inhibitor and a syk inhibitor, belonging to the autoimmune treatment class of molecules. | CC(NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cccnc34)nc12)C(=O)N1CC(N)C1 | [
"jak inhibitor",
"autoimmune treatment",
"syk inhibitor"
] |
The molecule is a anti inflammatory. | CCc1cc(-c2cccc(OCCCCCN3CCCC3)c2)cc(CC)c1CC | [
"anti inflammatory"
] |
The molecule is a electroluminescent device, fluorescent, and electroluminescent compound. | CC1(C)C2=CC3=C4C(=CC(Br)=CC4O)C=C3C(O)C2=Cc2ccc(Br)cc21 | [
"electroluminescent device",
"fluorescent",
"electroluminescent"
] |
The molecule is a nutrient that impacts both cardiovascular disease and pancreatitis. The molecule is a fat storage and belongs to the thyroxine treatment class of molecules, impacting both atherosclerosis and metabolic syndrome. | CC/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)OC[C@H](COC(=O)CCCCCC/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC | [
"Cardiovascular disease",
"nutrient",
"Pancreatitis",
"Atherosclerosis",
"Metabolic syndrome",
"Fat storage",
"Thyroxine treatment"
] |
The molecule is a proton trap for oxidative phosphorylation, stabilizing mitochondrial structure, apoptosis that impacts barth syndrome and tangier disease. The molecule is a stabilizing cytochrome oxidase and a cholesterol translocation that impacts diabetic heart disease, aging, and non-alcoholic fatty liver disease. | CCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCCC(C)C | [
"Barth syndrome",
"Proton trap for oxidative phosphorylation",
"Tangier disease",
"Stabilizing mitochondrial structure",
"Apoptosis",
"Diabetic heart disease",
"Stabilizing cytochrome oxidase",
"Cholesterol translocation",
"Aging",
"Non-alcoholic fatty liver disease"
] |
The molecule is a stabilizing mitochondrial structure and a proton trap for oxidative phosphorylation that impacts tangier disease, non-alcoholic fatty liver disease, and barth syndrome. The molecule is a stabilizing cytochrome oxidase, cholesterol translocation, apoptosis that impacts aging and diabetic heart disease. | CCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C | [
"Tangier disease",
"Non-alcoholic fatty liver disease",
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Proton trap for oxidative phosphorylation",
"Aging",
"Stabilizing cytochrome oxidase",
"Cholesterol translocation",
"Diabetic heart disease",
"Apoptosis"
] |
It impacts atherosclerosis, cardiovascular disease, and thyroxine treatment. The molecule is a fat storage and a nutrient, impacting both pancreatitis and metabolic syndrome. | CC/C=C\C/C=C\C/C=C\C/C=C\CCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCCCCCC/C=C\CCCCCCCC | [
"Atherosclerosis",
"Cardiovascular disease",
"Thyroxine treatment",
"Pancreatitis",
"Fat storage",
"Metabolic syndrome",
"nutrient"
] |
The molecule is a proton trap for oxidative phosphorylation and a stabilizing cytochrome oxidase, impacting both non-alcoholic fatty liver disease and barth syndrome. The molecule is a nutritional supplement, emulsifier, apoptosis that impacts tangier disease and aging. The molecule is a membrane stabilizer, energy storage, energy source, surfactant. The molecule is a cholesterol translocation, a stabilizing mitochondrial structure, and a food additive, it impacts diabetic heart disease and is smooth. | CCC(C)CCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCC(C)C | [
"Proton trap for oxidative phosphorylation",
"Stabilizing cytochrome oxidase",
"Non-alcoholic fatty liver disease",
"Barth syndrome",
"Nutritional supplement",
"Emulsifier",
"Tangier disease",
"Aging",
"Apoptosis",
"Membrane stabilizer",
"Energy storage",
"Energy source",
"surfactant",
"Diabetic heart disease",
"Smooth",
"Cholesterol translocation",
"Stabilizing mitochondrial structure",
"food additive"
] |
It belongs to the cancer treatment class of molecules. | COc1ncc(-c2ccc3c(Nc4cccc(B(O)O)c4)c(S(=O)(=O)NC4CC4)cnc3c2)c(OC)n1 | [
"cancer treatment"
] |
The molecule is a apoptosis, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation that impacts tangier disease and diabetic heart disease. The molecule is a cholesterol translocation and a stabilizing cytochrome oxidase that impacts aging, non-alcoholic fatty liver disease, and barth syndrome. | CC/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CCCC/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCCCCCCCCCC | [
"Tangier disease",
"Apoptosis",
"Stabilizing mitochondrial structure",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Cholesterol translocation",
"Aging",
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase",
"Barth syndrome"
] |
The molecule is a cholesterol translocation, apoptosis, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts barth syndrome. The molecule is a proton trap for oxidative phosphorylation that impacts tangier disease, aging, non-alcoholic fatty liver disease, and diabetic heart disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCC/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCC/C=C\CCCCCC | [
"Cholesterol translocation",
"Apoptosis",
"Stabilizing cytochrome oxidase",
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Proton trap for oxidative phosphorylation",
"Tangier disease",
"Aging",
"Non-alcoholic fatty liver disease",
"Diabetic heart disease"
] |
The molecule is a inflammatory, nutrient, membrane stabilizer, energy storage that belongs to the thyroxine treatment class of molecules and impacts obesity. The molecule is a fat storage and energy source with an effect on cancer. It impacts pancreatitis, metabolic syndrome, atherosclerosis, and cardiovascular disease. | CCC(C)CCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C | [
"Thyroxine treatment",
"inflammatory",
"nutrient",
"Membrane stabilizer",
"Obesity",
"Energy storage",
"Fat storage",
"Energy source",
"Cancer",
"Pancreatitis",
"Metabolic syndrome",
"Atherosclerosis",
"Cardiovascular disease"
] |
The molecule is a energy storage, nutrient, inflammatory, fat storage that impacts cardiovascular disease and pancreatitis. The molecule is a energy source that impacts both cancer and atherosclerosis. The molecule is a membrane stabilizer and a thyroxine treatment, impacting both obesity and metabolic syndrome. | CCCCCCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCC(C)CC | [
"Energy storage",
"nutrient",
"inflammatory",
"Fat storage",
"Cardiovascular disease",
"Pancreatitis",
"Energy source",
"Cancer",
"Atherosclerosis",
"Obesity",
"Membrane stabilizer",
"Metabolic syndrome",
"Thyroxine treatment"
] |
The molecule is a apoptosis and a stabilizing cytochrome oxidase that impacts non-alcoholic fatty liver disease, aging, and barth syndrome. The molecule is a cholesterol translocation, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation that impacts tangier disease and diabetic heart disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)O[C@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC | [
"Non-alcoholic fatty liver disease",
"Aging",
"Apoptosis",
"Barth syndrome",
"Stabilizing cytochrome oxidase",
"Tangier disease",
"Cholesterol translocation",
"Stabilizing mitochondrial structure",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation"
] |
The molecule is a apoptosis, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase that impacts aging and diabetic heart disease. The molecule is a cholesterol translocation and a stabilizing mitochondrial structure that impacts barth syndrome, tangier disease, and non-alcoholic fatty liver disease. | Nc1ccccc1S(=O)(=O)O | [
"Aging",
"Diabetic heart disease",
"Apoptosis",
"Proton trap for oxidative phosphorylation",
"Stabilizing cytochrome oxidase",
"Barth syndrome",
"Cholesterol translocation",
"Tangier disease",
"Stabilizing mitochondrial structure",
"Non-alcoholic fatty liver disease"
] |
It impacts seizure, alzheimer's disease, cardiovascular disease, and breast cancer. It impacts colorectal cancer, parkinson's disease, stomach cancer, and diabetes mellitus. | CC/C=C\C/C=C\C/C=C\C/C=C\CCCCCCCCC(=O)OC[C@H](COP(=O)(O)O[C@H]1C(O)C(O)C(O)[C@@H](OP(=O)(O)O)C1O)OC(=O)CCC/C=C\C/C=C\CC1OC1C/C=C\CCCCC | [
"Seizure",
"Alzheimer's Disease",
"Cardiovascular disease",
"Breast cancer",
"Colorectal cancer",
"Parkinson's disease",
"Stomach cancer",
"Diabetes mellitus"
] |
It has an effect on stomach cancer, and impacts seizure, alzheimer's disease, and breast cancer. It impacts cardiovascular disease, diabetes mellitus, colorectal cancer, and parkinson's disease. | CC/C=C\CC1OC1C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)(O)O[C@H]1C(O)C(O)C(O)[C@@H](OP(=O)(O)O)C1O)OC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC | [
"Seizure",
"Stomach cancer",
"Alzheimer's Disease",
"Breast cancer",
"Cardiovascular disease",
"Diabetes mellitus",
"Colorectal cancer",
"Parkinson's disease"
] |
The molecule is a proton trap for oxidative phosphorylation and a stabilizing mitochondrial structure that impacts aging, tangier disease, and non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase, cholesterol translocation, apoptosis that impacts barth syndrome and diabetic heart disease. | CCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C | [
"Aging",
"Proton trap for oxidative phosphorylation",
"Stabilizing mitochondrial structure",
"Tangier disease",
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase",
"Cholesterol translocation",
"Barth syndrome",
"Apoptosis",
"Diabetic heart disease"
] |
The molecule is a energy storage, surfactant, proton trap for oxidative phosphorylation, emulsifier. The molecule is a stabilizing mitochondrial structure, nutritional supplement, cholesterol translocation, food additive that impacts barth syndrome. The molecule is a stabilizing cytochrome oxidase and a energy source, it impacts aging, and is smooth. The molecule is a apoptosis and a membrane stabilizer that impacts diabetic heart disease, tangier disease, and non-alcoholic fatty liver disease. | CCCCC/C=C\C/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OCCCCCCCCC/C=C\CCCCCCC=O | [
"Energy storage",
"surfactant",
"Proton trap for oxidative phosphorylation",
"Emulsifier",
"Stabilizing mitochondrial structure",
"Nutritional supplement",
"Cholesterol translocation",
"food additive",
"Barth syndrome",
"Stabilizing cytochrome oxidase",
"Energy source",
"Smooth",
"Aging",
"Diabetic heart disease",
"Apoptosis",
"Membrane stabilizer",
"Tangier disease",
"Non-alcoholic fatty liver disease"
] |
The molecule is a cholesterol translocation and a stabilizing cytochrome oxidase that impacts non-alcoholic fatty liver disease, tangier disease, and diabetic heart disease. The molecule is a proton trap for oxidative phosphorylation, stabilizing mitochondrial structure, apoptosis that impacts barth syndrome and aging. | CCCCCC/C=C\C=C/CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCCCC | [
"Non-alcoholic fatty liver disease",
"Tangier disease",
"Cholesterol translocation",
"Stabilizing cytochrome oxidase",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Stabilizing mitochondrial structure",
"Apoptosis",
"Barth syndrome",
"Aging"
] |
Subsets and Splits